DBD-ED,
189373-41-9,
4-(2-Aminoethylamino)-7-(N,N-dimethylsulfamoyl)benzofurazan,
4-(N,N-Dimethylaminosulfonyl)-7-(2-aminoethylamino)-2,1,3-benzoxadiazole,
DBD-ED [=4-(N,N-Dimethylaminosulfonyl)-7-(2-aminoethylamino)-2,1,3-benzoxadiazole] [for HPLC Labeling],
AC1N4AJ7,
CHEMBL1632606,
SCHEMBL15877765,
CTK4E0122,
DTXSID60399604,
ZINC2379569,
MFCD01321129,
RTR-008779,
J-012220,
4-(Dimethylaminosulfonyl)-7-[(2-aminoethyl)amino]benzofurazane,
7-(2-Aminoethylamino)-N,N-dimethyl-4-benzofurazansulfonamide,
2,1,3-Benzoxadiazole-4-sulfonamide,7-[(2-aminoethyl)amino]-N,N-dimethyl-,
7-(2-aminoethylamino)-N,N-dimethyl-2,1,3-benzoxadiazole-4-sulfonamide,
7-(2-aminoethylamino)-N,N-dimethylbenzo[c][1,2,5]oxadiazole-4-sulfonamide,
4-(2-Aminoethylamino)-7-(N,N-dimethylsulfamoyl)benzofurazan, for HPLC derivatization, >=99.0% (HPLC),
CID4125780,
CID 4125780,
A5574,